MedTrace Logo

OLE Study to Evaluate Safety / Efficacy of ZD4522

NCT00654303 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 3500

Last updated 2009-03-16

No results posted yet for this study

Summary

The purpose of this study is to assess the long term safety of Crestor.

Conditions

  • Hypercholesterolaemia

Interventions

DRUG

Rosuvastatin

Sponsors & Collaborators

Principal Investigators

  • Elinor Miller, MD · AstraZeneca

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-08-31
Completion
2005-02-28

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00654303 on ClinicalTrials.gov